Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma.
Saved in:
| Title: | Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. |
|---|---|
| Authors: | Chen, Ping1,2 (AUTHOR), Wang, Mengchi2,3 (AUTHOR), Peng, Siyan1,2,3 (AUTHOR), Zhu, Honglin1,2,4 (AUTHOR), Wang, Yanming1,2,5 (AUTHOR), Wan, Zixuan3 (AUTHOR), Yang, Xuan1,4 (AUTHOR), Yu, Zhixin2,5 (AUTHOR), Zhou, Yixin1,2 (AUTHOR) |
| Source: | Current Oncology. Mar2026, Vol. 31 Issue 3, p173. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol33030173 |
